concurrent chemotherapy + Definitive hypofractionated intensity-modulated radiation theraphy for uterine cervical neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Dec 2025: Trial started, NCT07439497
  2. 27 Feb 2026: Trial registered, NCT07439497

The trials

NCT07439497: Definitive Hypofractionated Intensity-modulated Radiation Theraphy With Concurrent Chemotherapy in Cervical Cancer

State
Under way
Phase
Phase 2
People
34 planned
Started
9 Dec 2025
Primary completion
30 May 2026
Arms
Definitive hypofractionated intensity-modulated radiation theraphy with concurrent chemotherapy
Results
None posted
  1. 9 Dec 2025: Trial started
  2. 27 Feb 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.